COSCIENS Biopharma Inc (CSCI)

Toronto
Currency in CAD
4.670
-0.150(-3.11%)
Closed·
CSCI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
4.4904.820
52 wk Range
2.90010.240
Key Statistics
Edit
Bid/Ask
4.55 / 4.90
Prev. Close
4.82
Open
4.82
Day's Range
4.49-4.82
52 wk Range
2.9-10.24
Volume
7.33K
Average Volume (3m)
1.69K
1-Year Change
-22.68%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CSCI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

COSCIENS Biopharma Inc News & Analysis

Show more

COSCIENS Biopharma Inc Company Profile

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce inflammation for the healthcare and cosmetic industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as for endocrinology and oncology indications. The company sells its products through its distribution network. It has license agreements with Pharmanovia, MegaPharm Ltd., ER Kim Pharmaceuticals Bulgaria Eood, and NK MEDITECH Ltd, as well as Agriculture Canada and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.

Compare CSCI to Peers and Sector

Metrics to compare
CSCI
Peers
Sector
Relationship
P/E Ratio
−0.6x−3.5x−0.5x
PEG Ratio
0.000.110.00
Price/Book
1.1x2.5x2.6x
Price / LTM Sales
1.2x4.2x3.0x
Upside (Analyst Target)
-256.4%52.6%
Fair Value Upside
Unlock14.3%8.8%Unlock

Earnings

Latest Release
Apr 09, 2025
EPS / Forecast
-2.14 / -3.48
Revenue / Forecast
3.32M / 1.10M
EPS Revisions
Last 90 days

CSCI Income Statement

FAQ

What Is the COSCIENS Biopharma (CSCI) Stock Price Today?

The COSCIENS Biopharma stock price today is 4.67

What Stock Exchange Does COSCIENS Biopharma Trade On?

COSCIENS Biopharma is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for COSCIENS Biopharma?

The stock symbol for COSCIENS Biopharma is "CSCI."

What Is the COSCIENS Biopharma Market Cap?

As of today, COSCIENS Biopharma market cap is 14.70M.

What Is COSCIENS Biopharma's Earnings Per Share (TTM)?

The COSCIENS Biopharma EPS (TTM) is -6.04.

From a Technical Analysis Perspective, Is CSCI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has COSCIENS Biopharma Stock Split?

COSCIENS Biopharma has split 5 times.

How Many Employees Does COSCIENS Biopharma Have?

COSCIENS Biopharma has 40 employees.

What is the current trading status of COSCIENS Biopharma (CSCI)?

As of 21 Jun 2025, COSCIENS Biopharma (CSCI) is trading at a price of 4.67, with a previous close of 4.82. The stock has fluctuated within a day range of 4.49 to 4.82, while its 52-week range spans from 2.90 to 10.24.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.